| scholarly article | Q13442814 |
| P50 | author | Naji Abumrad | Q28873689 |
| Charles Robert Flynn | Q42550013 | ||
| Vance L. Albaugh | Q56997870 | ||
| Robyn A Tamboli | Q87677542 | ||
| P2093 | author name string | Yi Xiao | |
| Steven Cai | |||
| P2860 | cites work | The Role of Bile After Roux-en-Y Gastric Bypass in Promoting Weight Loss and Improving Glycaemic Control | Q24629879 |
| FXR signaling in the enterohepatic system | Q27014753 | ||
| FXR is a molecular target for the effects of vertical sleeve gastrectomy | Q28236848 | ||
| Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation | Q28290455 | ||
| Bile salt biotransformations by human intestinal bacteria | Q29622858 | ||
| Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults | Q34023422 | ||
| Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women. | Q34024266 | ||
| Reduction in inflammatory gene expression in skeletal muscle from Roux-en-Y gastric bypass patients randomized to omentectomy | Q34110159 | ||
| Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity | Q34146701 | ||
| Ileal interposition improves glucose tolerance and insulin sensitivity in the obese Zucker rat. | Q34178868 | ||
| Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice | Q34304725 | ||
| Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist | Q34326973 | ||
| Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity | Q34661023 | ||
| Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity. | Q34996610 | ||
| Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials | Q35024182 | ||
| Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure | Q35128295 | ||
| The gut microbiome, probiotics, bile acids axis, and human health. | Q35170147 | ||
| Effect of Roux-en-Y gastric bypass surgery on bile acid metabolism in normal and obese diabetic rats | Q35208562 | ||
| Long-term follow-up after bariatric surgery: a systematic review. | Q35237039 | ||
| The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor κ light-chain enhancer of activated B cells (NF-κB) in mice | Q35249092 | ||
| Temporal changes in bile acid levels and 12α-hydroxylation after Roux-en-Y gastric bypass surgery in type 2 diabetes. | Q35577851 | ||
| Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass | Q35591749 | ||
| Hepatic and peripheral insulin sensitivity and diabetes remission at 1 month after Roux-en-Y gastric bypass surgery in patients randomized to omentectomy | Q35620195 | ||
| Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity | Q35672242 | ||
| Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery. | Q35703158 | ||
| Bariatric surgery versus intensive medical therapy in obese patients with diabetes | Q36025669 | ||
| Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism | Q36381636 | ||
| Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids. | Q36736464 | ||
| Performance characteristics of reversed-phase bonded silica cartridges for serum bile acid extraction | Q36821518 | ||
| A Role for Fibroblast Growth Factor 19 and Bile Acids in Diabetes Remission After Roux-en-Y Gastric Bypass | Q36942098 | ||
| Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment | Q37022586 | ||
| Human insulin resistance is associated with increased plasma levels of 12α-hydroxylated bile acids | Q37333477 | ||
| Bile acids as regulators of hepatic lipid and glucose metabolism | Q37749352 | ||
| Metabolic surgery for type 2 diabetes | Q37898157 | ||
| Beyond intestinal soap--bile acids in metabolic control. | Q38211374 | ||
| Bile acids and gut peptide secretion after bariatric surgery: A 1‐year prospective randomized pilot trial | Q42440562 | ||
| Vertical sleeve gastrectomy reduces hepatic steatosis while increasing serum bile acids in a weight-loss-independent manner | Q42873394 | ||
| Enhanced fasting and post-prandial plasma bile acid responses after Roux-en-Y gastric bypass surgery. | Q44581393 | ||
| Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery. | Q45943724 | ||
| Improved analysis of bile acids in tissues and intestinal contents of rats using LC/ESI-MS. | Q46388559 | ||
| Improvements in glucose metabolism early after gastric bypass surgery are not explained by increases in total bile acids and fibroblast growth factor 19 concentrations | Q51310555 | ||
| Inhibition of farnesoid X receptor signaling shows beneficial effects in human obesity | Q57144678 | ||
| Use of dual-energy X-ray absorptiometry in obese individuals | Q71774521 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | E1225-33 | |
| P577 | publication date | 2015-07-21 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Early Increases in Bile Acids Post Roux-en-Y Gastric Bypass Are Driven by Insulin-Sensitizing, Secondary Bile Acids | |
| P478 | volume | 100 |
| Q26750607 | A healthy gastrointestinal microbiome is dependent on dietary diversity |
| Q92435693 | Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters |
| Q90221587 | Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease |
| Q49899707 | Bariatric Surgery: A Perspective for Primary Care |
| Q90274929 | Bile Acids as Metabolic Regulators and Nutrient Sensors |
| Q92875316 | Bile acid changes after metabolic surgery are linked to improvement in insulin sensitivity |
| Q57109538 | Bile acid metabolites in early pregnancy and risk of gestational diabetes in Chinese women: A nested case-control study |
| Q39228891 | Bile acids and bariatric surgery |
| Q92130960 | Bilio-enteric flow and plasma concentrations of bile acids after gastric bypass and sleeve gastrectomy |
| Q51245210 | CD36 modulates fasting and preabsorptive hormone and bile acid levels. |
| Q37033105 | Cholesterol 7α-hydroxylase-deficient mice are protected from high-fat/high-cholesterol diet-induced metabolic disorders |
| Q90016044 | GLP-1: Molecular mechanisms and outcomes of a complex signaling system |
| Q90608440 | Gut microbiota and health: connecting actors across the metabolic system |
| Q90028679 | Impaired Chylomicron Assembly Modifies Hepatic Metabolism Through Bile Acid-Dependent and Transmissible Microbial Adaptations |
| Q57291221 | Improvement of Glucose Metabolism Following Long-Term Taurocholic Acid Gavage in a Diabetic Rat Model |
| Q57115133 | Increased Bile Acids and FGF19 After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Correlate with Improvement in Type 2 Diabetes in a Randomized Trial |
| Q46561979 | Influence of Roux-en-Y gastric bypass on plasma bile acid profiles: a comparative study between rats, pigs and humans. |
| Q53784109 | Mechanisms of Diabetes Improvement Following Bariatric/Metabolic Surgery |
| Q91919560 | Metabolic Effects of Bile Acids: Potential Role in Bariatric Surgery |
| Q26741066 | Novel Molecules Regulating Energy Homeostasis: Physiology and Regulation by Macronutrient Intake and Weight Loss |
| Q57136131 | Obesity diabetes and the role of bile acids in metabolism |
| Q38965089 | Physiological and molecular responses to bariatric surgery: markers or mechanisms underlying T2DM resolution? |
| Q55084988 | Recent advancements in bariatric/metabolic surgery. |
| Q26745203 | Recent advances in metabolic and bariatric surgery |
| Q93174230 | Role of Bile Acids and GLP-1 in Mediating the Metabolic Improvements of Bariatric Surgery |
| Q64084972 | Role of Bile Acids in Bariatric Surgery |
| Q57129815 | Roux-en-Y gastric bypass increases systemic but not portal bile acid concentrations by decreasing hepatic bile acid uptake in minipigs |
| Q37121652 | Serum bile acids and GLP-1 decrease following telemetric induced weight loss: results of a randomized controlled trial |
| Q47144515 | Should Roux-en-Y gastric bypass biliopancreatic limb length be tailored to achieve improved diabetes outcomes? |
| Q91701518 | Systemic bile acids induce insulin resistance in a TGR5-independent manner |
| Q38913696 | The Contributing Role of Bile Acids to Metabolic Improvements After Obesity and Metabolic Surgery |
| Q48143632 | The Gastrointestinal Tract as an Integrator of Mechanical and Hormonal Response to Nutrient Ingestion |
| Q38288183 | The ratio of dihomo-γ-linolenic acid to deoxycholic acid species is a potential biomarker for the metabolic abnormalities in obesity. |
| Q38656970 | The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis |
| Q55555487 | What Has Bariatric Surgery Taught Us About the Role of the Upper Gastrointestinal Tract in the Regulation of Postprandial Glucose Metabolism? |
Search more.